These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Active and passive immunization against hepatitis B virus infection].
    Author: Colak H.
    Journal: Mikrobiyol Bul; 1982 Jan; 16(1):71-6. PubMed ID: 7144619.
    Abstract:
    Immune serum globulin and hepatitis B immunoglobulin are used for prevention and prophylaxis in hepatitis B virus infection. These are effective against pre- and postexposure cases. Hepatitis B immunoglobulin is more effective than immune serum globulin. Hepatitis B virus vaccines are prepared from HBsAg and its polypeptides. The vaccines prevent from hepatitis B infection in a high percentage. Antibody response for HBsAg vaccines are about 95 percent. Hemodialysis units personnel and patients, surgeons, dentists, male homosexuals and infants in endemic areas must be vaccinated with HBsAg vaccines.
    [Abstract] [Full Text] [Related] [New Search]